Antibodies 2022, 11(3), 56; https://doi.org/10.3390/antib11030056 - 26 Aug 2022
Best Paper Award
Dear Colleagues,
We are pleased to announce the “Antibodies 2022 Best Paper Award” for research and review articles published in Antibodies from 1 January 2022 to 31 December 2022. The paper will be selected after thorough evaluation by the journal Award Committee led by the EiCs, and the winner will be announced on 31 July 2024.
Eligibility for the awards:
– Papers published in Antibodies from 1 January 2022 to 31 December 2022;
– Open to all career levels;
– Both regular and Special Issue submissions will be considered.
Selection Criteria:
The papers will be selected by the journal Award Committee according to the following criteria (data source: Web of Science (Clarivate Analytics)):
– Scientific merit and broad impact;
– Relevance to the journal’s field;
– Originality of the research objectives and/or the ideas presented;
– Creativity of the study design or uniqueness of the approaches and concepts;
– Clarity of presentation;
– Citation and download rates in 2023.
Prizes:
– One review/research article award: CHF 500 and a chance to publish a paper free of charge in Antibodies before 30 December 2025;
– The winner will also receive a certificate.
The winner will be announced on the journal website on 31 July 2024.
Kind regards,
Antibodies Editorial Office
Antibodies Best Paper Award
Eligibility and Requirements
– All papers published in Antibodies will be eligible (Both regular and Special Issue submissions).
Past Winners
Year:
Winner
Alternative Routes of Administration for Therapeutic Antibodies—State of the Art
Award Committee
Prof. Arne Skerra
Chairman
Dr. Pablo Engel
Department of Biomedical Sciences
Prof. Dr. Buyong Ma
Prof. Mattias Collin
Lund University
Winner
Mark L. Chiu
Drug Product Development Science, Janssen Research & Development, LLC, Malvern, PA 19355, USA
